PSA outcomes in patients with adenocarcinoma of the prostate with presenting PSA > 20 ng/ml

被引：0
|
作者：
Shasha, Daniel
Debenham, Brock John
Salant, Robert
Harrison, Louis Benjamin
机构：
[1] Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, New York, NY 10003 USA
[2] Beth Israel Deaconess Med Ctr, Dept Urol, New York, NY 10003 USA
[3] St Lukes Roosevelt Hosp, New York, NY 10025 USA
[4] Beth Israel Deaconess Med Ctr, Continuum Canc Ctr New York, New York, NY 10003 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.241
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
241
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Outcomes of men who present with elevated serum PSA (>20 ng/mL) to an inner-city hospital
    Anai, Satoshi
    West, Shawn
    Chang, Myron
    Nakamura, Kogenta
    Pendleton, John
    Rosser, Charles J.
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2007, 99 (08) : 895 - 899
  • [22] IS IT SUITABLE TO ELIMINATE BONE SCAN FOR PROSTATE CANCER PATIENTS WITH PSA ≤20 NG/ML IN KOREAN POPULATION?
    Yeom, Chan Dong
    Lee, Seung Hwan
    Chung, Mun Su
    Park, Kyung Kgi
    Mah, Sang Yol
    Chung, Byung Ha
    [J]. JOURNAL OF UROLOGY, 2011, 185 (04): : E359 - E360
  • [23] IS IT SUITABLE TO ELIMINATE BONE SCAN FOR PROSTATE CANCER PATIENTS WITH PSA ≤20 NG/ML IN KOREAN POPULATION?
    Yom, C. D.
    Lee, S. H.
    Chung, M. S.
    Park, K. K.
    Chung, B. H.
    Mah, S. Y.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 271 - 271
  • [24] Sentinel lymph node resection in prostate cancer patients with PSA higher than 20 NG/ML
    Gronau, E
    Weckermann, D
    Harzmann, R
    [J]. JOURNAL OF UROLOGY, 2005, 173 (04): : 437 - 437
  • [25] Value of initial prostate-specific antigen (PSA) for predicting the post-prostatectomy PSA progression in patients with initial PSA≥20 ng/ml and no distant metastases
    Choi, Young Deuk
    Ham, Won Sik
    Cho, Kang Su
    Jung, Won Suk
    Kim, Sang Woon
    Lee, Joong Shik
    Kim, Dong Suk
    [J]. JOURNAL OF UROLOGY, 2008, 179 (04): : 401 - 401
  • [26] Development and validation of a nomogram for predicting prostate cancer in patients with PSA ≤ 20 ng/mL at initial biopsy
    Wu, Qiang
    Li, Fanglong
    Yin, Xiaotao
    Gao, Jiangping
    Zhang, Xu
    [J]. MEDICINE, 2021, 100 (50) : E28196
  • [27] IS MRI AND FUSION BIOPSIES NECESSARY IN PATIENTS WITH PSA LEVELS > 10 NG/ML?
    Rovesti, Lorenzo Maria
    Lombardo, Riccardo
    Nacchia, Antonio
    Riolo, Sara
    Cicione, Antonio
    Turchi, Beatrice
    Gallo, Giacomo
    Gravina, Carmen
    Guercio, Alessandro
    Stira, Jordi
    Franco, Antonio
    Di Giacomo, Ferdinando
    Disabato, Giuseppe
    Guarnotta, Giorgio
    Mancini, Elisa
    Voglino, Olivia Alessandra
    Baldassarri, Valeria
    D'Annunzio, Simone
    De Nunzio, Cosimo
    Tubaro, Andrea
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : E991 - E991
  • [28] Pathologic stage and surgical outcomes of prostate cancer with PSA < 4 ng/ml
    Gashti, SN
    Han, M
    Hawkins, SA
    Roehl, KA
    Loeb, S
    Catalona, WJ
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 170 - 171
  • [29] Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL
    Ang, Mann
    Rajcic, Branimir
    Foreman, Darren
    Moretti, Kim
    O'Callaghan, Michael E.
    [J]. BJU INTERNATIONAL, 2016, 117 : 68 - 75
  • [30] PSA of 0.5 ng/mL or less and prostate cancer radiation
    Anscher, MS
    [J]. UROLOGY, 1998, 52 (03) : 531 - 531
12345